FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats

[1]  E. Bui,et al.  Pharmacotherapy of anxiety disorders in the 21st century: A call for novel approaches , 2019, General Psychiatry.

[2]  D. Finn,et al.  FAAH, but not MAGL, inhibition modulates acute TLR3‐induced neuroimmune signaling in the rat, independent of sex , 2018, Journal of neuroscience research.

[3]  D. Finn,et al.  Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: An effect partially mediated by central TRPV1 , 2017, Brain, Behavior, and Immunity.

[4]  J. Kelly,et al.  Sex differences and similarities in depressive- and anxiety-like behaviour in the Wistar-Kyoto rat , 2016, Physiology & Behavior.

[5]  R. Witkamp.  Fatty acids, endocannabinoids and inflammation. , 2016, European journal of pharmacology.

[6]  J. Kelly,et al.  Characterization of the Affective Component of Acute Postoperative Pain Associated with a Novel Rat Model of Inguinal Hernia Repair Pain , 2016, CNS neuroscience & therapeutics.

[7]  D. Finn,et al.  For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  D. Finn,et al.  High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity , 2015, The international journal of neuropsychopharmacology.

[9]  N. Sudo,et al.  Prior chronic stress induces persistent polyI:C-induced allodynia and depressive-like behavior in rats: Possible involvement of glucocorticoids and microglia , 2015, Physiology & Behavior.

[10]  C. Cunningham,et al.  Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C , 2015, Brain, Behavior, and Immunity.

[11]  A. Komaki,et al.  Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze , 2015, Basic and clinical neuroscience.

[12]  A. Lichtman,et al.  Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function , 2015, Journal of Neuroimmune Pharmacology.

[13]  J. Kelly,et al.  Development and characterization of a novel, anatomically relevant rat model of acute postoperative pain. , 2015, The journal of pain : official journal of the American Pain Society.

[14]  M. Leite,et al.  Central mediators involved in the febrile response induced by polyinosinic–polycytidylic acid: Lack of involvement of endothelins and substance P , 2015, Journal of Neuroimmunology.

[15]  D. Finn,et al.  Neuroinflammatory Mechanisms Linking Pain and Depression. , 2015, Modern trends in pharmacopsychiatry.

[16]  J. Leza,et al.  Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats , 2015, The international journal of neuropsychopharmacology.

[17]  D. Finn,et al.  FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus , 2014, Journal of Neuroimmunology.

[18]  D. Finn,et al.  Minocycline modulates neuropathic pain behaviour and cortical M1–M2 microglial gene expression in a rat model of depression , 2014, Brain, Behavior, and Immunity.

[19]  Yasuyoshi Watanabe,et al.  Brain Interleukin-1β and the Intrinsic Receptor Antagonist Control Peripheral Toll-Like Receptor 3-Mediated Suppression of Spontaneous Activity in Rats , 2014, PloS one.

[20]  J. Fichna,et al.  Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  D. Finn,et al.  Altered neuropathic pain behaviour in a rat model of depression is associated with changes in inflammatory gene expression in the amygdala , 2013, Genes, brain, and behavior.

[22]  Q. Pittman,et al.  Cannabinoid 1 receptors are critical for the innate immune response to TLR4 stimulation. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[23]  M. Lynch,et al.  Toll‐like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon‐β , 2013, Hippocampus.

[24]  D. Finn,et al.  Alterations in the endocannabinoid system in the rat valproic acid model of autism , 2013, Behavioural Brain Research.

[25]  T. Yaksh,et al.  Spinal Toll-like receptor signaling and nociceptive processing: Regulatory balance between TIRAP and TRIF cascades mediated by TNF and IFNβ , 2013, PAIN®.

[26]  T. Connor,et al.  Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression , 2013, Brain, Behavior, and Immunity.

[27]  D. Boger,et al.  The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in mice , 2012, British journal of pharmacology.

[28]  D. Finn,et al.  Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor , 2012, Neuroscience.

[29]  A. Pastor,et al.  Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses , 2011, Biological Psychiatry.

[30]  A. A. Romanovsky,et al.  The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors , 2011, The Journal of physiology.

[31]  E. Downer.  Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation , 2011, TheScientificWorldJournal.

[32]  B. Oldfield,et al.  The endocannabinoid arachidonylethanolamide attenuates aspects of lipopolysaccharide-induced changes in energy intake, energy expenditure and hypothalamic Fos expression , 2011, Journal of Neuroimmunology.

[33]  Yun-qing Li,et al.  Ketamine Depresses Toll-Like Receptor 3 Signaling in Spinal Microglia in a Rat Model of Neuropathic Pain , 2011, Neurosignals.

[34]  H. Anisman,et al.  Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity , 2011, Brain, Behavior, and Immunity.

[35]  D. Finn,et al.  Enhanced nociceptive responding in two rat models of depression is associated with alterations in monoamine levels in discrete brain regions , 2010, Neuroscience.

[36]  O. Isacson,et al.  The Toll-Like Receptor-3 Agonist Polyinosinic:Polycytidylic Acid Triggers Nigrostriatal Dopaminergic Degeneration , 2010, The Journal of Neuroscience.

[37]  C. Cunningham,et al.  Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration , 2010, Brain, Behavior, and Immunity.

[38]  B. Cravatt,et al.  Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide Hydrolase , 2010, Journal of Pharmacology and Experimental Therapeutics.

[39]  A. K. Henderson,et al.  Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats , 2009, Neurobiology of Disease.

[40]  V. Marzo,et al.  Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels , 2009, Neuropsychopharmacology.

[41]  A. Lichtman,et al.  Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation , 2009, The AAPS Journal.

[42]  B. Lutz,et al.  Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors , 2008, Neuropharmacology.

[43]  Colm Cunningham,et al.  The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.

[44]  B. Gorzalka,et al.  Estrogen recruits the endocannabinoid system to modulate emotionality , 2007, Psychoneuroendocrinology.

[45]  C. Hillard,et al.  Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling , 2006, Journal of Pharmacology and Experimental Therapeutics.

[46]  M. Heinricher,et al.  Prostaglandin E2 in the medial preoptic area produces hyperalgesia and activates pain-modulating circuitry in the rostral ventromedial medulla , 2004, Neuroscience.

[47]  Stephen Kent,et al.  The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[48]  T. Kondo,et al.  Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-α mRNA in rats: a model for immunologically induced fatigue , 2003, Neuroscience.

[49]  S. Gaetani,et al.  Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.

[50]  Shosuke Takahashi,et al.  Prostanoids in the preoptic hypothalamus mediate systemic lipopolysaccharide-induced hyperalgesia in rats , 2001, Brain Research.

[51]  A. Milton,et al.  Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain , 2001, Pflügers Archiv.

[52]  M. Hosoi,et al.  Prostaglandin E receptor EP3 subtype is involved in thermal hyperalgesia through its actions in the preoptic hypothalamus and the diagonal band of Broca in rats , 1997, Pain.

[53]  Stephen P. Mayfield,et al.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides , 1996, Nature.